Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 7/2012

01-07-2012 | Original

Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample

Authors: Chai R. Soh, Ricardo Pietrobon, John J. Freiberger, Sophia T. Chew, Dimple Rajgor, Mihir Gandhi, Jatin Shah, Richard E. Moon

Published in: Intensive Care Medicine | Issue 7/2012

Login to get access

Abstract

Purpose

Necrotising soft tissue infection (NSTI) is a deadly disease associated with a significant risk of mortality and long-term disability from limb and tissue loss. The aim of this study was to determine the effect of hyperbaric oxygen (HBO2) therapy on mortality, complication rate, discharge status/location, hospital length of stay and inflation-adjusted hospitalisation cost in patients with NSTI.

Methods

This was a retrospective study of 45,913 patients in the Nationwide Inpatient Sample (NIS) from 1988 to 2009.

Results

A total of 405 patients received HBO2 therapy. The patients with NSTI who received HBO2 therapy had a lower mortality (4.5 vs. 9.4 %, p = 0.001). After adjusting for predictors and confounders, patients who received HBO2 therapy had a statistically significantly lower risk of dying (odds ratio (OR) 0.49, 95 % confidence interval (CI) 0.29–0.83), higher hospitalisation cost (US$52,205 vs. US$45,464, p = 0.02) and longer length of stay (LOS) (14.3 days vs. 10.7 days, p < 0.001).

Conclusions

This retrospective analysis of HBO2 therapy in NSTI showed that despite the higher hospitalisation cost and longer length of stay, the statistically significant reduction in mortality supports the use of HBO2 therapy in NSTI.
Literature
1.
Pizzorno R, Bonini F, Donelli A, Stubinski R, Medica M, Carmignani G (1997) Hyperbaric oxygen therapy in the treatment of Fournier’s disease in 11 male patients. J Urol 158:837–840PubMedCrossRef
2.
Rouse TM, Malangoni MA, Schulte WJ (1982) Necrotizing fasciitis: a preventable disaster. Surgery 92:765–770PubMed
3.
Escobar SJ, Slade JB Jr, Hunt TK, Cianci P (2005) Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med 32:437–443PubMed
4.
Elliott DC, Kufera JA, Myers RA (1996) Necrotizing soft tissue infections: risk factors for mortality and strategies for management. Ann Surg 224:672–683PubMedCrossRef
5.
George M, Rueth N, Skarda D, Chipman J, Quickel R, Beilman G (2009) Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect (Larchmt) 10:21–28CrossRef
6.
Jallali N, Withey S, Butler P (2005) Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg 189:462–466PubMedCrossRef
7.
Sarani B, Strong M, Pascual J, Schwab CW (2009) Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg 208:279–288PubMedCrossRef
8.
Mindrup SR, Kealey GP, Fallon B (2005) Hyperbaric oxygen for the treatment of Fournier’s gangrene. J Urol 173:1975–1977PubMedCrossRef
9.
Pietrobon R, Guller U, Martins H, Menezes AP, Higgins LD, Jacobs DO (2004) A suite of web applications to streamline the interdisciplinary collaboration in secondary data analyses. BMC Med Res Methodol 4:29PubMedCrossRef
10.
Shah J, Shah A, Pietrobon R (2009) Scientific writing of novice researchers: what difficulties and encouragements do they encounter? Acad Med 84:511–516PubMedCrossRef
11.
Deyo R, Cherkin D, Ciol M (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619PubMedCrossRef
12.
Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:41–55CrossRef
13.
Jackson RW, Waddell JP (1973) Hyperbaric oxygen in the management of clostridial myonecrosis (gas gangrene). Clin Orthop Relat Res 96:271–276PubMed
14.
Riseman JA, Zamboni WA, Curtis A, Graham DR, Konrad HR, Ross DS (1990) Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 108:847–850PubMed
15.
Korhonen K, Kuttila K, Niinikoski J (1999) Subcutaneous tissue oxygen and carbon dioxide tensions during hyperbaric oxygenation: an experimental study in rats. Eur J Surg 165:885–890PubMedCrossRef
16.
Korhonen K (2000) Hyperbaric oxygen therapy in acute necrotizing infections with a special reference to the effects on tissue gas tensions. Ann Chir Gynaecol Suppl:7–36
17.
Brummelkamp W, Hogendyk J, Boerema I (1961) Treatment of anaerobic infections by drenching the tissue with oxygen under high atmospheric pressure. Surgery 49:299–302
18.
19.
Mader JT, Brown GL, Guckian JC, Wells CH, Reinarz JA (1980) A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 142:915–922PubMedCrossRef
20.
Mader J, Adams K, Wallace W, Calhoun J (1990) Hyperbaric oxygen as adjunctive therapy for osteomyelitis. Infect Dis Clin North Am 4:433–440PubMed
21.
Mandell GL (1974) Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun 9:337–341PubMed
22.
Hohn DC, MacKay RD, Halliday B, Hunt TK (1976) Effect of O2 tension on microbicidal function of leukocytes in wounds and in vitro. Surg Forum 27:18–20PubMed
23.
Hunt TK, Linsey M, Grislis H, Sonne M, Jawetz E (1975) The effect of differing ambient oxygen tensions on wound infection. Ann Surg 181:35–39PubMedCrossRef
24.
Knighton DR, Halliday B, Hunt TK (1984) Oxygen as an antibiotic: the effect of inspired oxygen on infection. Arch Surg 119:199–204PubMedCrossRef
25.
Kaelin CM, Im MJ, Myers RA, Manson PN, Hoopes JE (1990) The effects of hyperbaric oxygen on free flaps in rats. Arch Surg 125:607–609PubMedCrossRef
26.
Rinaldi B, Cuzzocrea S, Donniacuo M, Capuano A, Di Palma D, Imperatore F, Mazzon E, Di Paola R, Sodano L, Rossi F (2011) Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures. Intensive Care Med 37:1110–1119PubMedCrossRef
27.
Knighton DR, Halliday B, Hunt TK (1986) Oxygen as an antibiotic: a comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch Surg 121:191–195PubMedCrossRef
28.
Unnika V (1965) Inhibition of toxin production in Clostridium perfringens in vitro by hyperbaric oxygen. Antonie Van Leeuwenhoek 31:181–186CrossRef
29.
Maclennan J, Macfarlane R (1945) Toxin and antitoxin studies of gas gangrene in man. Lancet 246:301–305CrossRef
30.
Marx RE, Ehler WJ, Tayapongsak P, Pierce LW (1990) Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 160:519–524PubMedCrossRef
31.
Hunt TK, Pai MP (1972) The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 135:561–567PubMed
32.
Clark LA, Moon RE (1999) Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir Care Clin N Am 5:203–219PubMed
33.
Brown D, Davis N, Lepawsky M, Cunningham J, Kortbeek J (1994) A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg 167:485–489PubMedCrossRef
34.
Majeski JA, Alexander JW (1983) Early diagnosis, nutritional support, and immediate extensive debridement improve survival in necrotizing fasciitis. Am J Surg 145:784–787PubMedCrossRef
35.
Stamenkovic I, Lew PD (1984) Early recognition of potentially fatal necrotizing fasciitis: the use of frozen-section biopsy. N Engl J Med 310:1689–1693PubMedCrossRef
36.
Boyer A, Vargas F, Coste F, Saubusse E, Castaing Y, Gbikpi-Benissan G, Hilbert G, Gruson D (2009) Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 35:847–853PubMedCrossRef
37.
Freischlag JA, Ajalat G, Busuttil RW (1985) Treatment of necrotizing soft tissue infections: the need for a new approach. Am J Surg 149:751–755PubMedCrossRef
38.
Kaul R, McGeer A, Low DE, Green K, Schwartz B (1997) Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 103:18–24PubMedCrossRef
39.
Mohammedi I, Ceruse P, Duperret S, Vedrinne J, Bouletreau P (1999) Cervical necrotizing fasciitis: 10 years’ experience at a single institution. Intensive Care Med 25:829–834PubMedCrossRef
40.
Metadata
Title
Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample
Authors
Chai R. Soh
Ricardo Pietrobon
John J. Freiberger
Sophia T. Chew
Dimple Rajgor
Mihir Gandhi
Jatin Shah
Richard E. Moon
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 7/2012
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-012-2558-4

Other articles of this Issue 7/2012

Intensive Care Medicine 7/2012 Go to the issue

Original

Safety of gelatin for volume resuscitation—a systematic review and meta-analysis

Pediatric Original

Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants after cardiothoracic surgery

Original

Increased nonbeneficial care in patients spending their birthday in the ICU

Conference Reports and Expert Panel

International evidence-based recommendations on ultrasound-guided vascular access

Original

Transpulmonary thermodilution measurements are not affected by continuous veno-venous hemofiltration at high blood pump flow

Pediatric Original

Incidence and risk factors for mortality in paediatric severe sepsis: results from the national paediatric intensive care registry in Japan